Stay updated with breaking news from Joseph Root. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Partnership will leverage Aspect's proprietary bioprinting technology and Novo Nordisk's expertise and technology in stem cell differentiation and cell therapy development and manufacturing. Aspect
Bagsværd, Denmark, 24 March 2023 - Novo Nordisk today announced headline results from the PIONEER PLUS trial, a phase 3b, 68-week, efficacy and safety trial with once-daily oral semaglutide 25 mg
Bagsværd, Denmark, 23 March 2023 - Today, Novo Nordisk A/S held its Annual General Meeting. At the Annual General Meeting, Helge Lund, Chair of the Board of Directors communicated: "We are very pleased
Bagsværd, Denmark,?2 March 2023 - Novo Nordisk just announced plans to expand its research and development (R&D) presence in the greater Boston metro area, creating one of its largest R&D hubs outside
Financial report for the period 1 January 2022 to 30 September 2022 Operating profit increased by 28% in Danish kroner and by 14% at constant exchange rates (CER) to DKK 57.7 billion. Sales in North